Pohlmann v. Purdue Pharma LP et al
| James Pohlmann |
| Janssen Pharmaceutica Inc., Purdue Pharma L.P., Mallinckrodt LLC, McKesson Corporation, Mallinckrodt PLC, Insys Therapeutics Inc., Watson Laboratories Inc., Allergan PLC, Teva Pharmaceuticals USA, Inc., Endo Pharmaceuticals Inc., Actavis LLC, Janssen Pharmaceutical, Inc., Cephalon Inc., Actavis Pharma, Inc., Cardinal Health Inc., Endo Health Solutions Inc., Johnson & Johnson, Watson Pharmaceuticals, Inc., AmerisourceBergen Drug Corporation, Teva Pharmaceuticals Industries Ltd., Purdue Frederick Company Inc., Noramco Inc, Morris & Dickson Co LLC, Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Purdue Pharma Inc. |
| 1:2018op46292 |
| December 3, 2018 |
| U.S. District Court for the Northern District of Ohio |
| Dan Aaron Polster (MDL 2804) |
| Racketeer/Corrupt Organization |
| 28 U.S.C. § 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 3, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 22 CASE TRANSFERRED IN from District of Louisiana Eastern. Case number 2:18-cv-09557. Original file, certified copy of transfer order and docket sheet received. |
Filing 21
Order of MDL Transfer to District of Ohio Northern. MDL case number is 2804. Electronic file, certified copy of transfer order, and docket sheet sent. (Attachments: #1 Transmittal Letter)(jeg) [Transferred from laed on 12/3/2018.]
|
| Filing 20 Notice of Conditional Transfer Order from MDL Panel regarding MDL 2804. (jeg) [Transferred from laed on 12/3/2018.] |
|
Filing 19
ORDER granting #18 MOTION to Continue Hearing on Plaintiff's Motion for Remand. Motion for Remand is continued to February 27, 2019 without oral argument. Signed by Judge Sarah S. Vance on 11/05/2018.(am) [Transferred from laed on 12/3/2018.]
|
| Filing 18 EXPARTE/CONSENT MOTION to Continue Hearing on Plaintiff's Motion for Remand by Janssen Pharmaceuticals, Inc., Johnson & Johnson, McKesson Corporation. (Attachments: #1 Proposed Order)(Williams, Stacey) [Transferred from laed on 12/3/2018.] |
|
Filing 17
ORDER denying #16 Request/Statement of Oral Argument. Signed by Judge Sarah S. Vance on 11/1/2018.(cg) [Transferred from laed on 12/3/2018.]
|
| Filing 16 Request/Statement of Oral Argument by James Pohlmann regarding #15 MOTION to Remand to State Court (Attachments: #1 Proposed Order)(Leger, Walter) [Transferred from laed on 12/3/2018.] |
| Filing 15 MOTION to Remand to State Court by James Pohlmann. Motion(s) will be submitted on 11/21/2018. (Attachments: #1 Memorandum in Support, #2 Notice of Submission, #3 Proposed Order)(Leger, Walter) [Transferred from laed on 12/3/2018.] |
| Filing 14 Statement of Corporate Disclosure by Janssen Pharmaceuticals, Inc., Johnson & Johnson. Janssen Pharmaceuticals, Inc. identifying Corporate Parent Janssen Pharmaceutica Inc., Corporate Parent Ortho-McNeil-Janssen Pharmaceuticals, Inc., Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. (Rookard, Kelly) Modified text on 10/31/2018 (am). [Transferred from laed on 12/3/2018.] |
| Filing 13 Notice of Compliance #1 Notice of Removal with 28 U.S.C. 1447(b) by Janssen Pharmaceuticals, Inc., Johnson & Johnson re #4 Order. (Attachments: #1 State Court Pleadings)(Rookard, Kelly) [Transferred from laed on 12/3/2018.] |
|
Filing 12
ORDER granting as Modified #10 Motion for Extension of Deadlines. Signed by Judge Sarah S. Vance on 10/30/2018. (am) [Transferred from laed on 12/3/2018.]
|
| Filing 11 Correction of Docket Entry by Clerk re #10 MOTION for Extension of Deadlines , #8 Statement of Corporate Disclosure, #9 Notice of Related Case(s), #7 Notice. **Name of attorney who electronically filed this document does not match name of signatory attorney on pleading. The user log-in and password serve as the required signature for purposes of Rule 11 of the FRCP. No further action is necessary.** (am) [Transferred from laed on 12/3/2018.] |
| Filing 10 EXPARTE/CONSENT MOTION for Extension of Deadlines by AmerisourceBergen Drug Corporation, Cardinal Health, Inc., McKesson Corporation. (Attachments: #1 Proposed Order)(Williams, Stacey) [Transferred from laed on 12/3/2018.] |
| Filing 9 Notice of Related Case(s) by McKesson Corporation. (Williams, Stacey) [Transferred from laed on 12/3/2018.] |
| Filing 8 Statement of Corporate Disclosure by McKesson Corporation (Williams, Stacey) [Transferred from laed on 12/3/2018.] |
| Filing 7 NOTICE by McKesson Corporation Supplemental Notice of Removal. (Attachments: #1 Exhibit)(Williams, Stacey) [Transferred from laed on 12/3/2018.] |
|
Filing 6
ORDER Granting as Modified #5 Motion for Extension of Time to Answer or Otherwise File Responsive Pleadings as to all Manufacturing Defendants up to and until thirty (30) days following the JPML's decision on transfer, or if transfer is denied, a ruling of this Courtregarding remand, should Plaintiff move to remand. Signed by Judge Sarah S. Vance on 10/22/2018. (am) [Transferred from laed on 12/3/2018.]
|
| Filing 5 EXPARTE/CONSENT MOTION for Extension of Time to Answer or Otherwise File Responsive Pleadings as to all Manufacturing Defendants by Janssen Pharmaceuticals, Inc., Johnson & Johnson. (Attachments: #1 Proposed Order)(Rookard, Kelly) [Transferred from laed on 12/3/2018.] |
| Filing 4 Directive of the Clerk regarding compliance with 28:1447(b) re #1 Notice of Removal, filed by Janssen Pharmaceuticals, Inc, Johnson & Johnson. By the Clerk.(am) [Transferred from laed on 12/3/2018.] |
| Filing 3 Correction of Docket Entry by Clerk re #1 Notice of Removal,**Exhibit 2 was imaged as 8-1/2" x 14". All documents should be 8-1/2" x 11". Clerk has corrected the image.** (am) [Transferred from laed on 12/3/2018.] |
| Filing 2 Initial Case Assignment to Judge Sarah S. Vance and Magistrate Judge Michael North. (cc) [Transferred from laed on 12/3/2018.] |
| Filing 1 NOTICE OF REMOVAL from 34th Judicial District Court, St. Bernard Parish, case number 18-1218 A (Filing fee $ 400 receipt number 053L-7172178) filed by Janssen Pharmaceuticals, Inc., Johnson & Johnson. (Attachments: #1 Civil Cover Sheet, #2 Exhibit 1, #3 Exhibit 2, #4 Collateral Pleadings Notice)Attorney Kelly Juneau Rookard added to party Janssen Pharmaceuticals, Inc.(pty:dft), Attorney Kelly Juneau Rookard added to party Johnson & Johnson(pty:dft).(Rookard, Kelly) Modified text on 10/16/2018 (am). (Attachment 3 replaced on 10/16/2018) (am). [Transferred from laed on 12/3/2018.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Ohio Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
